Braxia Scientific Reports Q1 2023 Financial Results; Launches KetaMD in U.S....
Download PDF TORONTO, ONTARIO August 29, 2022 – Braxia Scientific Corp. (“Braxia Scientific”, or the “Company”), (CSE: BRAX) (OTC: BRAXF) (FWB: 4960), a medical research and telemedicine company with...
View ArticleBraxia Scientific to Present at H.C. Wainwright 24th Annual Global Investment...
Download PDF TORONTO, ONTARIO September 9, 2022 – Braxia Scientific Corp. (“Braxia Scientific”, or the “Company”), (CSE: BRAX) (OTC: BRAXF) (FWB: 4960), a medical research and telemedicine company...
View ArticleBraxia Scientific Launches KetaMD in Florida; First Patients Complete Initial...
Download PDF TORONTO, ONTARIO September 12, 2022 – Braxia Scientific Corp. (“Braxia Scientific”, or the “Company”), (CSE: BRAX) (OTC: BRAXF) (FWB: 4960), a medical research and telemedicine company...
View ArticleBraxia Scientific Reports Q2 2023 Financial Results; Focused on Growing...
Download PDF Braxia Health clinic ketamine treatments up 34.5% YoY in Q2 2023 and revenue up 18% YoY Expanded clinic capacity with new, state-of-the-art clinic opened in Ottawa Closed acquisition of...
View ArticleIrwin Naturals Signs Letter of Intent to Acquire Braxia Scientific
Download PDF Strategic transaction assembles an experienced management and scientific team world-renowned in mental health treatment, research and development Establishes large footprint of 17...
View ArticleBraxia Scientific Announces Offering up to $1.5 Million, Braxia Management to...
Download PDF Download LIFE Offering TORONTO, ONTARIO February 7, 2023 – Braxia Scientific Corp. (“Braxia”, or the “Company”), (CSE: BRAX) (OTC: BRAXF) (FWB: 4960), a medical research company providing...
View ArticleBraxia Scientific Announces Closing of First Tranche of LIFE Offering and...
Download PDF TORONTO, ONTARIO February 27, 2023 – Braxia Scientific Corp. (“Braxia”, or the “Company”), (CSE: BRAX) (OTC: BRAXF) (FWB: 4960), a medical research company providing psychiatric,...
View ArticleBraxia Scientific Reports Q3 2023 Financial Results and Provides Update on...
Download PDF Braxia Health ketamine treatments up 29% YoY in Q3 2023 and revenue up 50.5% YoY TORONTO, ONTARIO Wednesday March 1, 2023 – Braxia Scientific Corp. (“Braxia Scientific”, or the...
View ArticleBraxia Scientific Reports Fiscal 2023 Financial Results
Braxia Health ketamine treatments up 26% YoY in 2023 and revenue up 27% YoY Company completes dosing of final participant in Phase 2, multi-dose Psilocybin trial, results expected to be published...
View ArticleBraxia Scientific Reports a 26% Increase in Total Treatment Volumes in F2023...
Company Taking Strategic Actions to Prioritize Clinic Expansion, Enhance Operational Effectiveness and Right Size Cost Structure. TORONTO, ONTARIO Monday June 12, 2023 – Braxia Scientific Corp....
View Article